| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 592* | 2021 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 281 | 2021 |
| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 278 | 2021 |
| Delaying surgery for patients with a previous SARS-CoV-2 infection Journal of British Surgery 107 (12), e601-e602, 2020 | 152 | 2020 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 109 | 2022 |
| Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic British Journal of Surgery 108 (1), 88-96, 2021 | 100 | 2021 |
| Chemoprevention of colorectal cancer by dietary compounds T Costea, A Hudiță, OA Ciolac, B Gălățeanu, O Ginghină, M Costache, ... International journal of molecular sciences 19 (12), 3787, 2018 | 100 | 2018 |
| Impact of multicellular tumor spheroids as an in vivo-like tumor model on anticancer drug response B Galateanu, A Hudita, C Negrei, RM Ion, M Costache, M Stan, D Nikitovic, ... International journal of oncology 48 (6), 2295-2302, 2016 | 68 | 2016 |
| Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic British Journal of Surgery 108 (12), 1448-1464, 2021 | 47 | 2021 |
| Novel chitosan and bacterial cellulose biocomposites tailored with polymeric nanoparticles for modern wound dressing development PO Stanescu, IC Radu, R Leu Alexa, A Hudita, E Tanasa, J Ghitman, ... Drug Delivery 28 (1), 1932-1950, 2021 | 47 | 2021 |
| Update on radionuclide therapy in oncology C Nitipir, D Niculae, C Orlov, MA Barbu, B Popescu, AM Popa, ... Oncology letters 14 (6), 7011-7015, 2017 | 46 | 2017 |
| Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, ... Anaesthesia 76 (11), 1454-1464, 2021 | 45 | 2021 |
| Poly (3-hydroxybutyrate-CO-3-hydroxyvalerate) PHBHV biocompatible nanocarriers for 5-FU delivery targeting colorectal cancer IC Radu, A Hudita, C Zaharia, B Galateanu, H Iovu, E Tanasa, ... Drug delivery 26 (1), 318-327, 2019 | 44 | 2019 |
| Poly (hydroxybutyrate-co-hydroxyvalerate)(PHBHV) nanocarriers for silymarin release as adjuvant therapy in colo-rectal cancer IC Radu, A Hudita, C Zaharia, PO Stanescu, E Vasile, H Iovu, M Stan, ... Frontiers in pharmacology 8, 508, 2017 | 43 | 2017 |
| Colon cancer cells gene expression signature as response to 5-fluorouracil, oxaliplatin, and folinic acid treatment C Negrei, A Hudita, O Ginghina, B Galateanu, SN Voicu, M Stan, ... Frontiers in pharmacology 7, 172, 2016 | 43 | 2016 |
| Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study C Fotopoulou, T Khan, J Bracinik, J Glasbey, N Abu-Rustum, L Chiva, ... American Journal of Obstetrics & Gynecology 227 (5), 735. e1-735. e25, 2022 | 41 | 2022 |
| Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries JC Glasbey, TEF Abbott, A Ademuyiwa, A Adisa, E Alameer, S Alshryda, ... The Lancet 400 (10363), 1607-1617, 2022 | 37 | 2022 |
| Liquid biopsy and artificial intelligence as tools to detect signatures of colorectal malignancies: a modern approach in patient’s stratification O Ginghina, A Hudita, M Zamfir, A Spanu, M Mardare, I Bondoc, ... Frontiers in Oncology 12, 856575, 2022 | 36 | 2022 |
| The development and validation of a rapid HPLC method for determination of piroxicam G Dragomiroiu, A Cimpoiesu, O Ginghina, C Baloescu, M Barca, DE Popa, ... Farmacia 63 (1), 123-131, 2015 | 36 | 2015 |
| EVALUATION OF ANTIMICROBIAL POTENTIAL OF NIGELLA SATIVA OIL IN A MODEL FOOD MATRIX. M Georgescu, PR TĂPĂLOAGĂ, D Tăpăloagă, F Furnaris, O Ginghină, ... Farmacia 66 (6), 2018 | 33 | 2018 |
Daniel BodaAssociate Professor, "Carol Daila" University of Medicine and Pharmacy, Bucharest, RomaniaVerified email at umf.ro
